Sentence examples for binding mechanisms for the from inspiring English sources
Azam, A. H., Hoshiga, F., Takeuchi, I., Miyanaga, K. & Tanji, Y. Analysis of phage resistance in Staphylococcus aureus SA003 reveals different binding mechanisms for the closely related Twort-like phages ɸSA012 and ɸSA039.
Despite the use of an identical receptor, the binding mechanisms for the two ligands differ, and the binding affinities between the individual ligand and receptor proteins vary dramatically (by a factor of 200 1000).
The sequences of SLII and SLIV are remarkably similar, and SNF binds to each with affinities that are uniquely dependent on salt and temperature, reflecting differences in binding mechanisms for the two RNAs.
The binding mechanism for the major site is likely conserved across circoviruses as supported by the similarity of NLSs in circovirus Caps.
Subsequent investigations examining salt effects suggested that the binding mechanism for the inhibitory region peptide is best characterized by an electrostatically driven fast on-rate (∼1×108 to 1×109 M−1 s−1) and a fast off-rate (∼1×102 s−1).
A two-step binding mechanism for the Eupergit C® immobilization process has been proposed.
A two-point binding mechanism for the cationic rhodium(I -catalyzed carbonyl-dI -catalyzedlytic asymmetric hydroboration of a carbonyl-directedrasymmetric is investigated using density functional thydroboration
Two different sequential binding mechanisms for ATP and the substrate have been proposed [ 15, 16], although the order in which ATP and the phosphoryl acceptor bind may occur randomly and may depend on the phosphoryl acceptor [ 15].
16 NMR characterization of the structures of several proteins revealed different binding mechanisms for even- and odd-numbered RRMs.
First, although the SH2 and PTB domains in tensin proteins have a high sequence homology, differences in their sequences may result in different binding mechanisms for DLC1 and other tensin family members.
Yang and co-workers [ 23] propose the concept of "Homopharma", to combine similar drug binding environments to better understand molecular binding mechanisms for deploying approved drugs for other diseases, known as "repurposing".
